Skip to main content
OpenTrials

Clinical trial condition

NSCLC Stage IV

Explore clinical trials studying NSCLC Stage IV. Study availability and eligibility vary by location and protocol.

54 public trials 21 recruiting studies
Refine in advanced search Browse all conditions

NSCLC Stage IV trial results

Active, Not Recruiting

1st Line Durvalumab in PS 2 NSCLC Patients

NCT03620669

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Kantonsspital Aarau Aarau, Switzerland
  • Kantonsspital Baden Baden, Switzerland
  • Universitaetsspital Basel Basel, Switzerland
  • IOSI Ospedale Regionale di Bellinzona e Valli Bellinzona, Switzerland
View Trial Details
Active, Not Recruiting

A Clinical Study to Evaluate the Efficacy and Safety of HLX26 (Anti-LAG-3 Monoclonal Antibody Injection) Combined With Serplulimab and Chemotherapy in Previously Untreated Advanced NSCLC Patients

NCT05787613

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • The Affiliated Hospital of Xuzhou Medical University Xuzhou, Jiangsu, China
  • Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
  • Shanghai Chest Hospital Shanghai, Shanghai Municipality, China
View Trial Details
Active, Not Recruiting

Phase 2 Study of Dacomitinib in NSCLC

NCT04027647

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
Locations
  • Prince of Wales Hospital Hong Kong
  • Sarawak General Hospital Kuching, Sarawak, Malaysia
  • University Malaya Medical Centre Kuala Lumpur, Malaysia
  • Beacon Hospital Petaling Jaya, Malaysia
View Trial Details

Related conditions